Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition

Background: Colon carcinomas frequently contain activating mutations in the K-ras proto-oncogene. K-ras itself is a poor drug target and drug development efforts have mostly focused on components of the classical Ras-activated MEK/ERK pathway. Here we have studied whether endogenous oncogenic K-ras...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Oncol
Main Authors: van Houdt, Winan J., de Bruijn, Menno T., Emmink, Benjamin L., Raats, Danielle, Hoogwater, Frederik J. H., Rinkes, Inne H. M. Borel, Kranenburg, Onno
Formato: Artigo
Idioma:Inglês
Publicado: IOS Press 2010
Assuntos:
Other
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4619241/
https://ncbi.nlm.nih.gov/pubmed/20413844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/CLO-2010-0521
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares